Search

Your search keyword '"Piemonti L"' showing total 588 results

Search Constraints

Start Over You searched for: Author "Piemonti L" Remove constraint Author: "Piemonti L"
588 results on '"Piemonti L"'

Search Results

1. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

3. Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation.

4. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

5. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

7. The immunological profile of SARS-CoV-2 infection in children is linked to clinical severity and age

10. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes

11. Targeting CXCR1/2 does not improve insulin secretion after pancreatic islet transplantation: A phase 3, double-blind, randomized, placebo-controlled trial in type 1 diabetes

16. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19

18. OP04.09: Impact of assisted reproductive techniques on congenital heart disease: insights from a tertiary care centre and literature review.

19. EP05.08: Antenatal visualisation of the caudo‐thalamic groove at expert fetal neurosonography.

20. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

25. Autoantibodies neutralizing type I IFNs are present in similar to 4\% of uninfected individuals over 70 years old and account for similar to 20\% of COVID-19 deaths

26. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

34. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

35. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

36. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

37. The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans

42. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]

46. The impact of proinflammatory cytokines on the beta-cell regulatory landscape provides insights into the genetics of type 1 diabetes

50. Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice

Catalog

Books, media, physical & digital resources